Chronic obstructive pulmonary disease (COPD).

[1]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[2]  R. Senior,et al.  The induction of emphysema with elastase. II. Changes in connective tissue. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[3]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.

[4]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[5]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[6]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[7]  V. Ferrans,et al.  Morphogenesis of abnormal elastic fibers in lungs of patients with panacinar and centriacinar emphysema. , 1989, Human pathology.

[8]  U. Kucich,et al.  Immunolocalization of elastase in human emphysematous lungs. , 1986, The Journal of clinical investigation.

[9]  D. Postma,et al.  The Dutch hypothesis (chronic non-specific lung disease) revisited. , 1991, The European respiratory journal.

[10]  R. K. Larson,et al.  The familial occurrence of chronic obstructive pulmonary disease. , 1965, Annals of internal medicine.

[11]  M. Becklake Chronic airflow limitation: its relationship to work in dusty occupations. , 1985, Chest.

[12]  W. Thurlbeck,et al.  Collagen and elastin in human pulmonary emphysema. , 1993, The American review of respiratory disease.

[13]  W. MacNee,et al.  Relation between distal airspace size, bronchiolar attachments, and lung function. , 1993, Thorax.

[14]  R. Albert,et al.  Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. , 1980, Annals of internal medicine.

[15]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[16]  M. Schluchter,et al.  Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. , 1996, American journal of respiratory and critical care medicine.

[17]  G. Snider,et al.  Relationship Between Elastolytic Activity and Experimental Emphysema-Inducing Properties of Papain Preparations1, 2 , 2015 .

[18]  D Lamb,et al.  Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. , 1994, Thorax.

[19]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[20]  J. Collet,et al.  Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.

[21]  E. Silverman,et al.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. , 1989, Annals of internal medicine.

[22]  R. Pierce,et al.  Developmental Regulation of Elastin Production. , 1995, The Journal of Biological Chemistry.

[23]  D. Niewoehner,et al.  Lung fibrosis and emphysema: divergent responses to a common injury? , 1982, Science.

[24]  B. Starcher,et al.  Urinary excretion of elastin peptides containing desmosin after intratracheal injection of elastase in hamsters. , 1978, The Journal of clinical investigation.

[25]  J. Wedzicha Inhaled corticosteroids in COPD: awaiting controlled trials. , 1993, Thorax.

[26]  S. Eriksson,et al.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY. , 2009, Acta medica Scandinavica.

[27]  S. Eriksson Studies in alpha 1-antitrypsin deficiency. , 1965, Acta medica Scandinavica. Supplementum.

[28]  D. Niewoehner,et al.  Pathologic changes in the peripheral airways of young cigarette smokers. , 1974, The New England journal of medicine.

[29]  L. Greenburg,et al.  On the production of emphysema in Syrian hamsters by aerosol inhalation of papain. , 1968, Archives of environmental health.

[30]  J A Pierce,et al.  Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. , 1991, The Journal of clinical investigation.

[31]  P. Macklem,et al.  Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease , 1992, The Lancet.

[32]  G. McLennan,et al.  Plasma elastin-derived peptide levels in normal adults, children, and emphysematous subjects. Physiologic and computed tomographic scan correlates. , 1992, The American review of respiratory disease.

[33]  X. Xu,et al.  Gender difference in smoking effects on adult pulmonary function. , 1994, The European respiratory journal.

[34]  R. Albert Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? No. , 1997, American journal of respiratory and critical care medicine.

[35]  T. De,et al.  Parenteral nutrition before gastrointestinal surgery. , 1982 .

[36]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[37]  W. MacNee,et al.  Microscopic and macroscopic measurements of emphysema: relation to carbon monoxide gas transfer. , 1992, Thorax.

[38]  W. Thurlbeck,et al.  Scanning electronmicroscopic morphometry of emphysema in humans. , 1994, American journal of respiratory and critical care medicine.

[39]  M. Schluchter,et al.  Baseline Characteristics of Enrollees in the National Heart, Lung and Blood Institute Registry of α1-Antitrypsin Deficiency , 1997 .

[40]  S. Shapiro,et al.  Mighty mice: transgenic technology "knocks out" questions of matrix metalloproteinase function. , 1997, Matrix biology : journal of the International Society for Matrix Biology.

[41]  D. Massaro,et al.  Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats , 1997, Nature Medicine.

[42]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[43]  G. O'Connor,et al.  Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. , 1996, American journal of respiratory and critical care medicine.

[44]  C. Laurell,et al.  The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .

[45]  D. Niewoehner,et al.  Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial. , 1987, Annals of internal medicine.

[46]  B. Burrows,et al.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.

[47]  M. Lebowitz,et al.  The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders. , 1982, The Journal of allergy and clinical immunology.

[48]  M. Lebowitz,et al.  Epidemiologic observations on eosinophilia and its relation to respiratory disorders. , 2015, The American review of respiratory disease.

[49]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[50]  J. Bloom,et al.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. , 1987, The New England journal of medicine.

[51]  R. Crystal,et al.  Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. , 1987, The Journal of clinical investigation.

[52]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.